A diabetes drug may beat costly shots for patients with a rare genetic condition, according to a Rutgers Health study.

Discover how tirzepatide, a diabetes drug, offers hope for congenital generalized lipodystrophy (CGL) treatment, potentially ...

the effects of too little leptin are widespread (including infertility, impaired immune function, decreased insulin response and altered homeostasis). Although leptin mutations are not common in ...

Sleep deprivation will increase the ghrelin hormone and decrease leptin. This leads to a greater feeling of hunger and dissatisfaction when you eat. The body sensitivity to insulin decreases with ...

A weekly diabetes medication may replace painful daily hormone injections for patients with congenital generalised lipodystrophy (CGL). Early findings suggest that tirzepatide – used for diabetes and ...

CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL: San Diego Friday, February 7, 2025, 15:00 Hr ...

Adequate sleep helps balance hunger hormones, preventing overeating and aiding weight management. Regular physical activity boosts metabolism, enhances fat burning, and builds muscle for higher ...

A weekly injection of diabetes medication could replace painful daily hormone shots for patients with a rare form of lipodystrophy.